Experience real-time quotes, in-depth charts, and analyst ratings

MARKET

IRIX

Iridex

NASDAQ

3.180

-0.090

-2.75%

Closed 16:00 04/17 EDT

OPEN

3.290

PREV CLOSE

3.270

HIGH

3.290

LOW

3.180

VOLUME

22.15K

TURNOVER

52 WEEK HIGH

3.650

52 WEEK LOW

1.310

MARKET CAP

51.68M

P/E (TTM)

-5.3589

Weekly Report: what happened at IRIX last week (0408-0412)?

Weekly Report · 3d ago

Weekly Report: what happened at IRIX last week (0401-0405)?

Weekly Report · 04/08 11:21

Weekly Report: what happened at IRIX last week (0325-0329)?

Weekly Report · 04/01 11:18

Iridex's Strategic Review Process Should Bear Fruit 'Soon'

Iridex Corporation is undergoing a strategic review process to unlock shareholder value. The company is likely to sell its retina business line and potentially parse it out "soon" The glaucoma business line is highly promising but needs to be in the hands of a bigger company to reach its full potential. Iridex is a leader in ophthalmic technology for the treatment of retinal and glau coma diseases. The entire business may be worth double the current share prices.

Seeking Alpha · 03/28 23:12

12 Health Care Stocks Moving In Thursday's After-Market Session

Qilian Intl Hldg Gr (NASDAQ:QLI) shares increased by 73.2% to $1.1 during Thursday's after-market session. Dare Bioscience stock rose 12.19% and Sunshine Biopharma stock increased by 37.85%. Vivos Therapeutics stock fell 12.6% as the company's Q4 earnings came out today.

Benzinga · 03/28 20:31

Analysts Have Conflicting Sentiments on These Healthcare Companies: Argenx Se (ARGX), Iridex (IRIX) and Keros Therapeutics (KROS)

TipRanks · 03/27 12:40

IRIX Stock Earnings: Iridex Misses EPS, Misses Revenue for Q4 2023

Iridex reported earnings per share of -18 cents. The company reported revenue of $12.46 million. This was 16.39% worse than the analyst estimate of $14.90 million for the quarter. The stock is down 2.7% today.

Investorplace · 03/27 00:53

Iridex (IRIX) Reports Q4 Loss, Lags Revenue Estimates

NASDAQ · 03/26 22:05

About IRIX

IRIDEX Corporation is an ophthalmic medical technology company. It develops and commercializes products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probes products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.

Webull offers IRIDEX Corp stock information, including NASDAQ: IRIX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IRIX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IRIX stock methods without spending real money on the virtual paper trading platform.